DFTX

AS OF

Jan 30 closing price

Price

$16.88

Change

-$0.36 (-2.09%)

Capitalization

1.66B

32 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

DFTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Definium Therapeutics (DFTX) Ownership - Who owns Definium Therapeutics?

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

DFTX

Capitalization

1.66B

P/E Ratio

N/A

Risk (Beta)

3.11

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

12.74

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

684M

Shares Outstanding - Current

98.5M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

26.064

View a ticker or compare two or three

Compare

DFTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for DFTX

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details